CENTRAL RETINAL VEIN OCCLUSION IN OTHERWISE HEALTHY CHILDREN AND ADOLESCENTS: Association With Multigenetic Variants of Thrombophilia
Research article published in Retina (Philadelphia, Pa.) (2020)
Abstract
PURPOSE: To report cases of central retinal vein occlusion in otherwise healthy children showing combined genetic variants of thrombophilia. METHODS: Ophthalmological, pediatric records and genetic analyses of thrombophilia-associated variants were retrospectively reviewed in four children diagnosed with central retinal vein occlusion. Genetic screening, including Factor XII, platelet glycoprotein (GP) IIIa PlA1/A2 (rs5918), and GPIa/IIa C807T (rs1126643) and G873A (rs1062535) mutations, was performed by PCR amplification and Sanger sequencing of PCR products. The genotyping of prothrombin G20210A, Leiden Factor V G1691A, methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C mutations, and plasminogen activator inhibitor-1 4G/5G polymorphisms was performed by real-time PCR with Fluorescence Resonance Energy Transfer (FRET) probes. RESULTS: The genotyping analysis identified combined genetic variants of thrombophilia in each patient. Mutations for MTHFR (C677T) and GPIIIa PlA1/A2 were detected in Case 1, mutations for MTHFR (C677T), GPIIIa PlA1/A2, and GPIa/IIa in Case 2, mutations for MTHFR (C677T) and GPIa/IIa in Case 3, and mutation for MTHFR (A12986C), GPIIIa Pl A1/A2, and GPIa/IIa in Case 4. Preventive low-dose aspirin therapy was prescribed to all patients. During a follow-up of 5 and 8 years, neither central retinal vein occlusion recurrence nor any other thrombotic event was observed in Cases 1 and 2, respectively. CONCLUSION: In otherwise healthy children presenting central retinal vein occlusion, genetic investigations for thrombophilia-associated variants should be considered, given the possible long-term benefit of aspirin prophylaxis.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Peer-reviewed clinical and outcomes research relevant to anticoagulation, leech therapy, and microsurgical flap management. Indexed in PubMed and verified against the NCBI record.
Por qué esto importa para la hirudoterapia
Esta serie de casos retrospectiva reporta a cuatro niños en general saludables con oclusión de la vena retinal central quienes, en el cribado genético, cada uno portaban variantes combinadas asociadas a trombofilia (el panel incluido en el cribado incluía MTHFR, glicoproteína plaquetaria GPIIIa/GPIa-IIa, protrombina G20210A, Factor V Leiden, PAI-1 y Factor XII), y quienes fueron manejados con aspirina preventiva de baja dosis; entre los casos con seguimiento reportado (Casos 1 y 2), no ocurrió recurrencia ni otro evento trombótico durante 5 y 8 años respectivamente. Su relevancia para la ASH es indirecta: subraya cómo se evalúan y manejan los eventos trombóticos venosos y los estados protrombóticos hereditarios, contexto adyacente a los temas de congestión venosa y trombosis en los que se discute la terapia con sanguijuelas y el secreto anticoagulante. Aviso: esta es una muy pequeña serie de casos pediátricos sobre trombofilia genética y profilaxis con aspirina en oclusión de la vena retinal; no implica sanguijuelas ni hirudoterapia y no apoya conclusiones causales ni terapéuticas sobre el tratamiento con sanguijuelas.
Citación
CENTRAL RETINAL VEIN OCCLUSION IN OTHERWISE HEALTHY CHILDREN AND ADOLESCENTS: Association With Multigenetic Variants of Thrombophilia.
BremondGignac et al. · Retina (Philadelphia, Pa.), 2020
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026